An overview of AMD
Age-related macular degeneration (AMD) is a progressive, sight-threatening disease that affects older adults, typically over the age of 65. In 2015, AMD was a leading cause of moderate or severe visual impairment, affecting 8.4 million people globally. With an aging population, the prevalence of AMD is increasing. In 2020, the global prevalence was estimated to be 196 million, and this is expected reach 288 million by 2040.
This article will provide a reminder of the pathophysiology and classification of AMD, before reviewing the current treatments and management options available. It will also discuss how to effectively and sensitively communicate AMD to patients, and highlight the information that should be provided.
This content is worth 1 CPD point and you can organise an optional discussion with a peer to earn interactive points.
CPD Points: 1
CPDpoints.com credits: 1
Expiry Date: 31/12/2022
Interactive points available
Also accepted by
A Guide to Incomitant Deviations
Many optometrists are uncomfortable with differentiating and managing incomitant deviations and this article aims improve knowledge and confidence in clinical decision making when presented with these patient cases. The main types of incommitant strabismus are summarised, including what to do when a patient presents with symptoms of various incommitant deviations.
This article provides a brief review of conditions that increase the risk of retinal detachment and includes 4 case studies.